Stryker Acquires Vertos Medical Inc.

Nevro Corp. Acquires Vyrsa Technologies

November 30, 2023

Medical Devices

Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.

VB Spine Acquires Stryker’s Spinal Implants Business in Australia and New Zealand

July 31, 2025

Medical Devices

VB Spine LLC has completed the acquisition of Stryker’s spinal implants business in Australia and New Zealand. The deal marks VB Spine’s first market entry outside the United States; LifeHealthcare will remain the exclusive distributor across both countries, and Viscogliosi Brothers LLC and Viscogliosi Brothers Watermark LLC are equity investors in VB Spine.

Viscogliosi Brothers Acquires Stryker's U.S. Spine Business to Create VB Spine

April 1, 2025

Medical Devices

Viscogliosi Brothers, a New York–based family office, completed the acquisition of Stryker's U.S. spine business and will operate it as VB Spine, LLC. Financial partners Barings and Texas Capital Bank supported the transaction; VB Spine aims to grow the business, expand globally and retain access to Stryker technologies such as Mako Spine and Copilot.

Stryker Acquires Cerus Endovascular

May 2, 2023

Medical Devices

Stryker has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage medical device company that developed the Contour Neurovascular System and Neqstent devices for treatment of intracranial aneurysms. The deal expands Stryker’s Neurovascular portfolio and strengthens its aneurysm/hemorrhagic treatment capabilities globally (reported purchase price approximately $530 million).

Stryker Acquires NICO Corporation

September 20, 2024

Medical Devices

Stryker has completed the acquisition of NICO Corporation, a privately held developer of minimally invasive neurosurgical systems including BrainPath and Myriad. The purchase expands Stryker's neurotechnology portfolio and strengthens its capabilities in tumor resection and treatment of intracerebral hemorrhage (stroke) worldwide.

Royal Philips Acquires Vesper Medical from Gilde Healthcare

December 14, 2021

Medical Devices

Royal Philips has signed an agreement to acquire Vesper Medical Inc., a US-based maker of minimally-invasive peripheral venous stent devices and a portfolio company of Gilde Healthcare. The acquisition will add Vesper's DUO Venous Stent System to Philips' image-guided therapy and peripheral vascular portfolio; the deal is expected to close in Q1 2022 and includes roughly 20 Vesper employees joining Philips.